基本信息
views: 18
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I was trained as a molecular biologist. I have a longstanding interest in the molecular mechanisms that affect drug response to therapy of metabolic diseases. In particular, I studied during my PhD the pharmacogenomics of statin response and I was trained in large-scale genotyping during a short-term visit at Centro Nacional de Genotipado (CEGEN), Santiago de Compostela, Spain. During my postdoc, I started working on microRNAs as master regulators of drug metabolism in the laboratory of Dr. Aiming Yu at SUNY, Buffalo, NY, as a visiting scholar. As soon as I returned to Brazil, I begun a new field of research in the Institute of Biomedical Sciences and received my first grant as a young investigator. The research aimed to discover microRNAs in diabetes and as targets of anti-hyperglycemic drugs. From 2013 to 2021 , I was an Assistant Professor of Pharmacology at the University of Sao Paulo (USP) and since 2021, I have been promoted to associate professor. My laboratory is currently focusing on discovering novel microRNAs in obesity and obesity-related disorders such as non-alcoholic steatosis that can be used in therapy and/or diagnosis. We are applying a variety of molecular and cellular approaches to study the effect of microRNAs in vivo. We have been using exosomes or electroporation of muscle to deliver microRNAs. As a principal investigator of a research laboratory and a faculty in the Institute of Biomedical Sciences, I am actively involved in collaboration.
Research Interests
Papers共 95 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of molecular endocrinologyno. 3 (2023)
ExRNA (2022): 2-2
Load More
Author Statistics
#Papers: 93
#Citation: 1920
H-Index: 28
G-Index: 38
Sociability: 6
Diversity: 3
Activity: 30
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn